Cite
HARVARD Citation
Prabhu, V. et al. (2018). Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection. Clinical infectious diseases. pp. 355-362. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prabhu, V. et al. (2018). Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection. Clinical infectious diseases. pp. 355-362. [Online].